Search alternatives:
ms decrease » _ decrease (Expand Search), nn decrease (Expand Search), use decreased (Expand Search)
we decrease » _ decrease (Expand Search), nn decrease (Expand Search), teer decrease (Expand Search)
a decrease » _ decrease (Expand Search), _ decreased (Expand Search), _ decreases (Expand Search)
ms decrease » _ decrease (Expand Search), nn decrease (Expand Search), use decreased (Expand Search)
we decrease » _ decrease (Expand Search), nn decrease (Expand Search), teer decrease (Expand Search)
a decrease » _ decrease (Expand Search), _ decreased (Expand Search), _ decreases (Expand Search)
-
16921
-
16922
S4 File -
Published 2023“…Non-severe-IRIS-KS was defined as: an increase in the number of lesions plus a decrease of ≥one log10 HIV-VL, or an increase of ≥50cells/mm3 or ≥2-fold in baseline CD4+cells. …”
-
16923
Screening diagram.
Published 2023“…Non-severe-IRIS-KS was defined as: an increase in the number of lesions plus a decrease of ≥one log10 HIV-VL, or an increase of ≥50cells/mm3 or ≥2-fold in baseline CD4+cells. …”
-
16924
IL6 levels by group by protocol scheduled visit.
Published 2023“…Non-severe-IRIS-KS was defined as: an increase in the number of lesions plus a decrease of ≥one log10 HIV-VL, or an increase of ≥50cells/mm3 or ≥2-fold in baseline CD4+cells. …”
-
16925
S1 File -
Published 2023“…Non-severe-IRIS-KS was defined as: an increase in the number of lesions plus a decrease of ≥one log10 HIV-VL, or an increase of ≥50cells/mm3 or ≥2-fold in baseline CD4+cells. …”
-
16926
Table_1_Medical errors, affected sites, and adverse consequences among patients in the orthopaedic department: Does age matter?.DOCX
Published 2024“…However, adult patients (aged 18–60 years) were most susceptible to errors in the extremities (30.42%). A higher rate of complications was associated with a higher rate of morbidity/mortality for the corresponding patients. …”
-
16927
Adverse events.
Published 2023“…Non-severe-IRIS-KS was defined as: an increase in the number of lesions plus a decrease of ≥one log10 HIV-VL, or an increase of ≥50cells/mm3 or ≥2-fold in baseline CD4+cells. …”
-
16928
-
16929
-
16930
Influence of high-dose gamma radiation and particle size on antioxidant properties of Maize ( Zea mays L.) flour
Published 2022“…A statistically significant dose-dependent decrease (p<0.05) in antioxidant properties of gamma irradiated flour was observed. …”
-
16931
Changes in mTOR related p-4EBP1 expression in samples of ALL patients after <i>in vivo</i> chemotherapy and in cultured ALL cells treated with rapamycin <i>in vitro</i>.
Published 2013“…A decrease in p-4EBP1 was associated with concomitant induction of apoptosis by rapamycin (>50% apoptotic cells in the first two samples; data not shown). …”
-
16932
Table1_Remagnetization of Carboniferous Limestone in the Zaduo Area, Eastern Qiangtang Terrane, and Its Tectonic Implications.XLSX
Published 2022“…The 11 site-mean directions yield a mean in-situ paleopole of 84.4°N, 200.3°E, and A<sub>95</sub> = 6.8°, which is coincident with the post ∼53 Myr (especially around 40 Ma) paleopoles of the region. …”
-
16933
Table2_Remagnetization of Carboniferous Limestone in the Zaduo Area, Eastern Qiangtang Terrane, and Its Tectonic Implications.XLSX
Published 2022“…The 11 site-mean directions yield a mean in-situ paleopole of 84.4°N, 200.3°E, and A<sub>95</sub> = 6.8°, which is coincident with the post ∼53 Myr (especially around 40 Ma) paleopoles of the region. …”
-
16934
Table3_Remagnetization of Carboniferous Limestone in the Zaduo Area, Eastern Qiangtang Terrane, and Its Tectonic Implications.XLSX
Published 2022“…The 11 site-mean directions yield a mean in-situ paleopole of 84.4°N, 200.3°E, and A<sub>95</sub> = 6.8°, which is coincident with the post ∼53 Myr (especially around 40 Ma) paleopoles of the region. …”
-
16935
Supplementary Figures S1-S11 from The Novel, Small-Molecule DNA Methylation Inhibitor SGI-110 as an Ovarian Cancer Chemosensitizer
Published 2023“…Comparison of cell growth rates of parental A2780 cells (A), A2780-CDDP resistant cells (B), and CP70 CDDP resistant cells (C) treated with 5μM 5-aza-dC, or vehicle (DMSO 1:2000) for 48 hours followed by CDDP ranging from 0-50μM CDDP. …”
-
16936
Working memory impairment, which is not delay-dependent in chronic PCP-treated mice.
Published 2017“…<p>(A) Experimental schedules for the discrete paired-trial variable-delay task in T-maze and the drug treatments. …”
-
16937
An explanation of the pRF dynamics in terms of feedback signals from extrastriate cortex.
Published 2013“…Interestingly, this model also predicts that increasing the size of the mask (shifting the fringe to the right) results in a decrease of the pRF expansion. This is indeed what appears to happen when the mask size increases from 5.0° to 7.5° (see <a href="http://www.plosone.org/article/info:doi/10.1371/journal.pone.0037686#pone-0037686-g004" target="_blank">Figure 4B</a> and corresponding text).…”
-
16938
Pulmonary elastin pattern in the fetal rabbit model for CDH undergoing TO.
Published 2013“…Open arrowheads indicate elastic fibers in the alveolar walls. <b>F</b>. The mean percentage of elastin-containing crests is decreased in DH lungs and restored by TO. …”
-
16939
Table_1_Diabetic and Elder Patients Experience Superior Cardiovascular Benefits After Gastric Bypass Induced Weight Loss.DOCX
Published 2018“…Patients with prior type 2 diabetes and aged 50 years or older experienced a significantly superior CV risk reduction, with diabetic patients experiencing a reduction of their 10–year CV disease risk of 3.58 ± 1.11% vs. a reduction of 1.31 ± 0.20% in non-diabetic patients and with the 10–year risk of CV disease dropping 3.41 ± 0.75% in patients older than 50 vs. a reduction of 0.99 ± 0.18 in patients up to 50 years. …”
-
16940
Image_1_Diabetic and Elder Patients Experience Superior Cardiovascular Benefits After Gastric Bypass Induced Weight Loss.JPEG
Published 2018“…Patients with prior type 2 diabetes and aged 50 years or older experienced a significantly superior CV risk reduction, with diabetic patients experiencing a reduction of their 10–year CV disease risk of 3.58 ± 1.11% vs. a reduction of 1.31 ± 0.20% in non-diabetic patients and with the 10–year risk of CV disease dropping 3.41 ± 0.75% in patients older than 50 vs. a reduction of 0.99 ± 0.18 in patients up to 50 years. …”